New study tests simpler abortion pill regimen for early pregnancy
NCT ID NCT07174856
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a misoprostol-only medication abortion regimen to the standard combined mifepristone and misoprostol regimen in people up to 77 days pregnant. About 1,900 participants will be randomly assigned to one of the two regimens and followed for up to 35 days. The goal is to see if the misoprostol-only regimen is as effective at completing the abortion without needing additional procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- misoprostol
- What this could lead to
- If successful, this could offer a simpler, more accessible medication abortion option using only misoprostol, potentially expanding access.
- What could go wrong
- This is a Phase 4 trial, but the misoprostol-only regimen may be less effective than the standard combined regimen, and side effects could differ.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION, MEDICAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Planned Parenthood Association of Utah
Salt Lake City, Utah, 84102, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.